AI assistant
Sending…
Immuneering Corp — Director's Dealing 2022
May 12, 2022
32973_dirs_2022-05-12_ac736207-8cba-483b-88b5-081ae8751f18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2022-05-12
Reporting Person: Amin Biren (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-12 | Class A Common Stock | P | 1000 | $4.42 | Acquired | 7898 | Direct |
More from Immuneering Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5